Farmacokinetiek en -dynamiek
Towards precision dosing in psychiatric patients
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Kajie Liang
- Promoters Birgit Koch
- Co-Promoters Bram Dierckx
- Jaar 2022- 2026
KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn69resultaten gevonden
Medicatieveiligheid
Improving pharmaceutical care for hospitalized patients
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Sarah Wilkes
- Promoters Hugo van der Kuy
- Co-Promoters R.J. Zaal
- Jaar 2022-2026
- Cost benefit analysis clinical medication reviews
- Follow up of interventions from clinical pharmacists.
- Medication information needs of hospitalized patients.
Farmacokinetiek en -dynamiek
Exploratory PK/PD study of beta-lactam antibiotics in pediatric intensive care patients
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Stef Schouwenburg
- Promoters Birgit Koch
- Co-Promoters E.D. (Enno) Wildschut M. (Matthijs) de Hoog
- Jaar 2021-2025
A prospective observational PK/PD to study the target attainment for β-lactam antibiotics in critically ill pediatric patients and associated risk factors.
Medicatieveiligheid
The role of the community pharmacist in diabetes care in Indonesia
- Universiteit Rijksuniversiteit Groningen
- Promovendus I. Cahyaningsih
- Promoters K. Taxis P. Denig
- Jaar 2021-2025
How to expand the role of the community pharmacist in Indonesia in diabetes care.
Medicatieveiligheid
Application of Multinational pharmacoepidemiologic studies
- Universiteit Rijksuniversiteit Groningen
- Promovendus Torre, C.O.
- Promoters K. Taxis I. Wong
- Jaar 2021-2025
The research project aims to perform a multinational pharmacoepidemiologic study in order to examine the mental health effects of the COVID-19 pandemic across vulnerable groups, including people with established psychiatric disorders including dementia and neurodevelopmental disorders.
Medicatiebeoordeling
Effects of Communication training to involve Older people in decisions to DEPRESCRIBE cardiometabolic medication: a cluster-randomized trial in primary care (CO-DEPRESCRIBE).
- Universiteit Rijksuniversiteit Groningen
- Promovendus Peter Stuijt
- Promoters Petra Denig Katja Taxis
- Jaar 2022-2026
Farmaco-economie
Cost-effectiveness of expensive drugs
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Shannon van der Zeeuw
- Promoters P.H.M. van der Kuy
- Co-Promoters M.B.S. Crombag T. Preijers
- Jaar 2024-2028
Hospital expenditure of expensive drugs increases yearly. In addition, shortages are becoming more common. To assure access to healthcare and treatment in the future, sustainable use of expensive drugs is very important. This research aims to optimize treatment with regard to efficacy and safety, while aiming to reduce drug costs.
Pagina 1 van 10